Plasma membrane Ca2+-ATPase isoform 4 antagonizes cardiac hypertrophy in association with calcineurin inhibition in rodents

Journal of Clinical Investigation

Volumn 119, Issue 4, 2009, Pages 976-985

  Wu, Xu ^a   Chang, Baojun ^a   Blair, N Scott ^a   Sargent, Michelle ^a   York, Allen J ^a   Robbins, Jeffrey ^a   Shull, Gary E ^a   Molkentin, Jeffery D ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; LUCIFERASE; PHENYLEPHRINE; PLASMA MEMBRANE CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; PLASMA MEMBRANE CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 4; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3; UNCLASSIFIED DRUG; ATP2B4 PROTEIN, HUMAN; RECOMBINANT PROTEIN; TRANSCRIPTION FACTOR NFAT;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; AORTA CONSTRICTION; ARTICLE; CALCIUM SIGNALING; ENZYME ACTIVITY; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; INHIBITION KINETICS; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TRANSGENIC MOUSE; ANIMAL; CARDIOMEGALY; CELL CULTURE; CELL MEMBRANE; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CALCINEURIN; CALCIUM SIGNALING; CARDIOMEGALY; CELL MEMBRANE; CELLS, CULTURED; HUMANS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MYOCYTES, CARDIAC; NFATC TRANSCRIPTION FACTORS; PLASMA MEMBRANE CALCIUM-TRANSPORTING ATPASES; RECOMBINANT PROTEINS;

EID: 65249128530     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI36693     Document Type: Article

References (34)

1. Lorell, B.H., and Carabello, B.A. 2000. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation. 102:470-479.
2. Ho, K.K., Levy, D., Kannel, W.B., and Pinsky, J.L. 1993. The epidemiology of heart failure: The Framingham study. J. Am. Coll. Cardiol. 22:6-13.
3. Lloyd-Jones, D.M., et al. 2002. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 106:3068-3072.
4. Molkentin, J.D., and Dorn, G.W., 2nd. 2001. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu. Rev. Physiol. 63:391-426.
5. Molkentin, J.D. 2006. Dichotomy of Ca2+ in the heart: contraction versus intracellular signaling. J. Clin. Invest. 116:623-626.
6. Wu, X., et al. 2006. Local InsP3-dependent perinuclear Ca2+ signaling in cardiac myocyte excitationtranscription coupling. J. Clin. Invest. 116:675-682.
7. Balijepalli, R.C., Foell, J.D., Hall, D.D., Hell, J.W., and Kamp, T.J. 2006. Localization of cardiac L-type Ca(2+) channels to a caveolar macromolecular signaling complex is required for beta(2)-adrenergic regulation. Proc. Natl. Acad. Sci. U. S. A. 103:7500-7505.
8. Freichel, M., et al. 1999. V. Store-operated cation channels in the heart and cells of the cardiovascular system. Cell Physiol. Biochem. 9:270-283.
9. Hunton, D.L., et al. 2002. Capacitative calcium entry contributes to nuclear factor of activated T-cells nuclear translocation and hypertrophy in cardiomyocytes. J. Biol. Chem. 277:14266-14273.
10. Hunton, D.L., Zou, L., Pang, Y., and Marchase, R.B. 2004. Adult rat cardiomyocytes exhibit capacitative calcium entry. Am. J. Physiol. Heart Circ. Physiol. 286:H1124-H1132.
11. Uehara, A., Yasukochi, M., Imanaga, I., Nishi, M., and Takeshima, H. 2002. Store-operated Ca2+ entry uncoupled with ryanodine receptor and junctional membrane complex in heart muscle cells. Cell Calcium. 31:89-96.
12. Nakayama, H., Wilkins, B.J., Bodi, I., and Molkentin, J.D. 2006. Calcineurin-dependent cardiomyopathy is activated by TRPC in the adult mouse heart. FASEB J. 20:1660-1670.
13. Bush, E.W., et al. 2006. Canonical transient receptor potential channels promote cardiomyocyte hypertrophy through activation of calcineurin signaling. J. Biol. Chem. 281:33487-33496.
14. Kuwahara, K., et al. 2006. TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling. J. Clin. Invest. 116:3114-3126.
15. Patel, H.H., Murray, F., and Insel, P.A. 2008. G-protein-coupled receptor-signaling components in membrane raft and caveolae microdomains. Handb. Exp. Pharmacol. 186:167-184.
16. Strehler, E.E., and Zacharias, D.A. 2001. Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. Physiol. Rev. 81:21-50.
17. Bers, D.M. 2001. Excitation-contraction coupling and cardiac contractile force. 2nd edition. Kluwer Academic Publishers. Dordrecht, The Netherlands. 427 pp.
18. Hammes, A., et al. 1998. Overexpression of the sarcolemmal calcium pump in the myocardium of transgenic rats. Circ. Res. 83:877-888.
19. Schuh, K., Uldrijan, S., Telkamp, M., Rothlein, N., and Neyses, L. 2001. The plasma membrane calmodulin-dependent calcium pump: a major regulator of nitric oxide synthase I. J. Cell Biol. 155:201-205.
20. Oceandy, D., et al. 2007. Neuronal nitric oxide synthase signaling in the heart is regulated by the sarcolemmal calcium pump 4b. Circulation. 115:483-492.
21. Buch, M.H., et al. 2005. The sarcolemmal calcium pump inhibits the calcineurin/nuclear factor of activated T-cell pathway via interaction with the calcineurin A catalytic subunit. J. Biol. Chem. 280:29479-29487.
22. Sanbe, A., et al. 2003. Reengineering inducible cardiac-specific transgenesis with an attenuated myosin heavy chain promoter. Circ. Res. 92:609-616.
23. Ambudkar, I.S., Brazer, S.C., Liu, X., Lockwich, T., and Singh, B. 2004. Plasma membrane localization of TRPC channels: role of caveolar lipid rafts. Novartis Found. Symp. 258:63-70.
24. Molkentin, J.D., et al. 1998. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 93:215-228.
25. Adamo, H.P., Filoteo, A.G., Enyedi, A., and Penniston, J.T. 1995. Mutants in the putative nucleotide-binding region of the plasma membrane Ca(2+)-pump. A reduction in activity due to slow dephosphorylation. J. Biol. Chem. 270:30111-30114.
26. Fujimoto, T. 1993. Calcium pump of the plasma membrane is localized in caveolae. J. Cell Biol. 120:1147-1157.
27. Amino, K., Honda, Y., Ide, C., and Fujimoto, T. 1997. Distribution of plasmalemmal Ca(2+)-pump and caveolin in the corneal epithelium during the wound healing process. Curr. Eye Res. 16:1088-1095.
28. Schnitzer, J.E., Oh, P., Jacobson, B.S., and Dvorak, A.M. 1995. Caveolae from luminal plasmalemma of rat lung endothelium: microdomains enriched in caveolin, Ca(2+)-ATPase, and inositol trisphosphate receptor. Proc. Natl. Acad. Sci. U. S. A. 92:1759-1763.
29. Oceandy, D., Stanley, P.J., Cartwright, E.J., and Neyses, L. 2007. The regulatory function of plasmamembrane Ca(2+)-ATPase (PMCA) in the heart. Biochem. Soc. Trans. 35:927-930.
30. Piuhola, J., et al. 2001. Overexpression of sarcolemmal calcium pump attenuates induction of cardiac gene expression in response to ET-1. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281:R699-R705.
31. Wilkins, B.J., et al. 2004. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ. Res. 94:110-118.
32. Okunade, G.W., et al. 2004. Targeted ablation of plasma membrane Ca2+-ATPase (PMCA) 1 and 4 indicates a major housekeeping function for PMCA1 and a critical role in hyperactivated sperm motility and male fertility for PMCA4. J. Biol. Chem. 279:33742-33750.
33. Kaiser, R.A., et al. 2005. Genetic inhibition or activation of JNK1/2 protects the myocardium from ischemia-reperfusion-induced cell death in vivo. J. Biol. Chem. 280:32602-32608.
34. Xu, J., et al. 2006. GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. Circ. Res. 98:342-350.